By RYAN ALLWAY December 13th, 2016 Source: SECFilings.com Cell MedX Corp. (OTCQB: CMXC), a development-stage biotech company focused on harnessing the power of microcurrent technologies to address numerous health conditions, recently expanded the potential addressable market for its eBalance Pro…